BioNote Inc. (377740.KS) stock: key figures, P/E, revenue and dividend
Health Care · Health Care Equipment · South Korea
BioNote Inc. financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 102.78 bn KRW | 118.32 bn KRW |
| Gross profit | 51.24 bn KRW | 65.77 bn KRW |
| Operating income | 12.22 bn KRW | 16.81 bn KRW |
| EBIT | 73.56 bn KRW | -87.28 bn KRW |
| Net income | 55.26 bn KRW | -87.50 bn KRW |
| Diluted EPS – continuing operations | 545.18 KRW | -867.02 KRW |
Full history since 2019, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About BioNote Inc.
BioNote, Inc., manufactures and sells in-vitro diagnostic animal medicines in South Korea. It offers animal diagnostics products, such as fluorescence immunoassay, molecular diagnostics, clinical biochemistry, rapid immunoassay, and enzyme-linked immunosorbent assay products. The company also provides bio-content products, including rapid immunoassay for humans, human intermediate goods, and bio-contents reagents. In addition, it engages in the production and sell of medical devices. BioNote, Inc. was founded in 2003 and is headquartered in Hwaseong-si, South Korea.
More stocks
- Huang Hsiang Construction Corp (2545.TW)
- Chinese Maritime Transport Ltd (2612.TW)
- GRAN TIERRA ENERGY INC. (GTE)
- Palm Landscape Architecture Co Ltd (002431.SZ)
- Shenzhen Longood Intelligent Electric Co Ltd Class A (300543.SZ)
- Stillfront Group AB (publ) (SF.ST)
- Zhejiang XinNong Chemical Co Ltd Class A (002942.SZ)
- KMC (Kuei Meng) International Inc (5306.TW)
- VIEMED HEALTHCARE, INC. (VMD)
- Linzhou Heavy Machinery Group Co Ltd (002535.SZ)
- Promotora de Informaciones SA (PRS.MC)
- Vitalhub Corp (VHI.TO)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.